Estradiol/Gestodene

雌二醇/孕二烯酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEstradiol/Gestodene
Drug Alias Name孕二烯酮/雌二醇半水合物Gestodene/estradiol hemihydrateGestodene/EthinylestradiolAvadenAvadene
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2003/11/21
Country/TerritoryFrance
CombinationsYes EstradiolGestodene
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeG03CA53
Related LinksN/A